Nicotine receptor partial agonists for smoking cessation

Measuring inconsistency in meta-analyses

Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works

Nicotine replacement therapy for smoking cessation

Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,514 · see citing works

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Jorenby, D. E. (2006) · JAMA · doi:10.1001/jama.296.1.56 · Cited by 1,635 · see citing works

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Gonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361 · see citing works

Antidepressants for smoking cessation

Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352 · see citing works

Outcome criteria in smoking cessation trials: proposal for a common standard

West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285 · see citing works

Pharmacological interventions for smoking cessation: an overview and network meta-analysis

Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243 · see citing works

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177 · see citing works

Measures of abstinence in clinical trials: issues and recommendations

Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058 · see citing works

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930 · see citing works

Nicotine receptor partial agonists for smoking cessation

Hey, K., Lancaster, T., & Bala, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103 · Cited by 864 · see citing works

Nicotine receptor partial agonists for smoking cessation

Cahill, K., Stead, L., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub2 · Cited by 747 · see citing works

Measures of abstinence in clinical trials: issues and recommendations

Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1080/1462220031000070552 · Cited by 712 · see citing works

Effect of Maintenance Therapy With Varenicline on Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Tonstad, S. (2006) · JAMA · doi:10.1001/jama.296.1.64 · Cited by 660 · see citing works

Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558 · see citing works

Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies

Mills, E. J., Thorlund, K., Eapen, S., Wu, P., & Prochaska, J. J. (2013) · Circulation · doi:10.1161/circulationaha.113.003961 · Cited by 405 · see citing works

Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up

Nides, M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1561 · Cited by 390 · see citing works

Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation

Oncken, C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1571 · Cited by 380 · see citing works

Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease

Rigotti, N. A., Pipe, A., Benowitz, N. L., Arteaga, C., Garza, D., & Tonstad, S. (2010) · Circulation · doi:10.1161/circulationaha.109.869008 · Cited by 364 · see citing works

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

Aubin, H.-J., Bobak, A., Britton, J. R., Oncken, C., Billing, C. B., Gong, J., Williams, K. E., & Reeves, K. R. (2008) · Thorax · doi:10.1136/thx.2007.090647 · Cited by 344 · see citing works

Antidepressants for smoking cessation.

Hughes, J., Stead, L., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub4 · Cited by 317 · see citing works

A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., et al. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31829623f4 · Cited by 287 · see citing works

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis

Singh, S., Loke, Y. K., Spangler, J. G., & Furberg, C. D. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110218 · Cited by 286 · see citing works

Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit

Papke, R. L., & Heinemann, S. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09896-7 · Cited by 259 · see citing works

Cytisine versus Nicotine for Smoking Cessation

Walker, N. K., Howe, C., Glover, M., McRobbie, H. J., Barnes, J., Nosa, V. H., Parag, V., Bassett, B., & Bullen, C. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407764 · Cited by 251 · see citing works

Placebo-controlled trial of cytisine for smoking cessation

West, R., Zatonski, W., Cedzynska, M., Lewandowska, D., Pazik, J., Aveyard, P., & Stapleton, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102035 · Cited by 234 · see citing works

Varenicline improves mood and cognition during smoking abstinence

Patterson, F., Jepson, C., Strasser, A. A., Loughead, J., Perkins, K. A., Gur, R. C., Frey, J. M., Siegel, S., & Lerman, C. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.028 · Cited by 222 · see citing works

Effect of Varenicline on Smoking Cessation Through Smoking Reduction

Ebbert, J. O., Hughes, J. R., West, R., Rennard, S. I., Russ, C., McRae, T. D., Treadow, J., Yu, C., Dutro, M. P., & Park, P. W. (2015) · JAMA · doi:10.1001/jama.2015.280 · Cited by 210 · see citing works

Effects of Varenicline on Smoking Cessation in Patients With Mild to Moderate COPD

Tashkin, D. P., Rennard, S. I., Hays, J. T., Ma, W., Lawrence, D., & Lee, T. C. (2010) · CHEST Journal · doi:10.1378/chest.10-0865 · Cited by 209 · see citing works

Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder: A Randomized Clinical Trial

Evins, A. E., Cather, C., Pratt, S. A., Pachas, G. N., Hoeppner, S. S., Goff, D. C., Achtyes, E. D., Ayer, D., & Schoenfeld, D. A. (2014) · JAMA · doi:10.1001/jama.2013.285113 · Cited by 207 · see citing works

Varenicline Treatment of Concurrent Alcohol and Nicotine Dependence in Schizophrenia

Meszaros, Z. S., Abdul-Malak, Y., Dimmock, J. A., Wang, D., Ajagbe, T. O., & Batki, S. L. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182870551 · Cited by 206 · see citing works

Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness

Stapleton, J., Watson, L. A., Spirling, L. I., Smith, R. C., Milbrandt, A., Ratcliffe, M., & Sutherland, G. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02083.x · Cited by 206 · see citing works

Cytisine for smoking cessation: a literature review and a meta-analysis.

Etter, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1553 · Cited by 206 · see citing works

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt

West, R., Baker, C. L., Cappelleri, J. C., & Bushmakin, A. G. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1041-3 · Cited by 203 · see citing works

NICOTINE ADDICTION

Benowitz, N. L. (1999) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70120-2 · Cited by 203 · see citing works

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis

Prochaska, J. J., & Hilton, J. F. (2012) · BMJ · doi:10.1136/bmj.e2856 · Cited by 202 · see citing works

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database

Gunnell, D., Irvine, D., Wise, L., Davies, C., & Martin, R. M. (2009) · BMJ · doi:10.1136/bmj.b3805 · Cited by 200 · see citing works

Working memory deficits predict short-term smoking resumption following brief abstinence

Patterson, F., Jepson, C., Loughead, J., Perkins, K. A., Strasser, A. A., Siegel, S. J., Frey, J. M., Gur, R. C., & Lerman, C. E. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.07.020 · Cited by 190 · see citing works

Nicotine receptor partial agonists for smoking cessation

Cahill, K., Stead, L. F., & Lancaster, T. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub5 · Cited by 187 · see citing works

Interventions for smokeless tobacco use cessation

Ebbert, J. O., Elrashidi, M. Y., & Stead, L. F. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004306.pub5 · Cited by 186 · see citing works

Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers

Nakamura, M., Oshima, A., Fujimoto, Y., Maruyama, N., Ishibashi, T., & Reeves, K. R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.06.012 · Cited by 185 · see citing works

A double-blind study evaluating the long-term safety of varenicline for smoking cessation

Williams, K. E., Reeves, K. R., Billing, C. B., Pennington, A. M., & Gong, J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x182185 · Cited by 184 · see citing works

Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks

Baker, T. B., Piper, M. E., Stein, J. H., Smith, S. S., Bolt, D. M., Fraser, D. L., & Fiore, M. C. (2016) · JAMA · doi:10.1001/jama.2015.19284 · Cited by 181 · see citing works

Varenicline decreases alcohol consumption in heavy-drinking smokers

Mitchell, J., Teague, C. H., Kayser, A. S., Bartlett, S. E., & Fields, H. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2717-x · Cited by 179 · see citing works

Nicotine receptor partial agonists for smoking cessation

Cahill, K., Stead, L. F., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub6 · Cited by 177 · see citing works

Efficacy of Varenicline Combined With Nicotine Replacement Therapy vs Varenicline Alone for Smoking Cessation

Koegelenberg, C. F. N., Noor, F., Bateman, E. D., van Zyl-Smit, R. N., Bruning, A., O’Brien, J., Smith, C., Abdool-Gaffar, M. S., Emanuel, S., Esterhuizen, T. M., et al. (2014) · JAMA · doi:10.1001/jama.2014.7195 · Cited by 169 · see citing works

Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis

Mills, E. J., Wu, P., Lockhart, I., Thorlund, K., Puhan, M. A., & Ebbert, J. O. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.705016 · Cited by 163 · see citing works

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder

Williams, J. M., Anthenelli, R. M., Morris, C. D., Treadow, J., Thompson, J. R., Yunis, C., & George, T. P. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07522 · Cited by 162 · see citing works

Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis

Thomas, K. H., Martin, R. M., Knipe, D. W., Higgins, J. P. T., & Gunnell, D. (2015) · BMJ · doi:10.1136/bmj.h1109 · Cited by 155 · see citing works

Suicidal Behavior and Depression in Smoking Cessation Treatments

Moore, T. J., Furberg, C. D., Glenmullen, J., Maltsberger, J. T., & Singh, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027016 · Cited by 150 · see citing works

Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder

Hong, L. E. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.83 · Cited by 150 · see citing works

Cigarettes and suicide: a prospective study of 50,000 men

(2000) · American Journal of Public Health · doi:10.2105/ajph.90.5.768 · Cited by 148 · see citing works

Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline: A Pooled Analysis

Tonstad, S., Davies, S., Flammer, M., Russ, C., & Hughes, J. (2010) · Drug Safety · doi:10.2165/11319180-000000000-00000 · Cited by 142 · see citing works

Varenicline, Smoking Cessation, and Neuropsychiatric Adverse Events

Gibbons, R. D., & Mann, J. J. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12121599 · Cited by 142 · see citing works

Combination Varenicline and Bupropion SR for Tobacco-Dependence Treatment in Cigarette Smokers

Ebbert, J. O., Hatsukami, D. K., Croghan, I. T., Schroeder, D. R., ALLEN, S. S., Hays, J. T., & Hurt, R. D. (2014) · JAMA · doi:10.1001/jama.2013.283185 · Cited by 137 · see citing works

Effects of Varenicline and Bupropion Sustained-Release Use Plus Intensive Smoking Cessation Counseling on Prolonged Abstinence From Smoking and on Depression, Negative Affect, and Other Symptoms of Nicotine Withdrawal

Cinciripini, P. M., Robinson, J. D., Karam-Hage, M., Minnix, J. A., Lam, C., Versace, F., Brown, V. L., Engelmann, J. M., & Wetter, D. W. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.678 · Cited by 136 · see citing works

Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression

Anthenelli, R. M., Morris, C. D., Ramey, T. S., Dubrava, S., Tsilkos, K., Russ, C., & Yunis, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00005 · Cited by 136 · see citing works

A randomized, placebo-controlled trial of varenicline, a selective α4β2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers

Tsai, S.-T., Cho, H., Cheng, H., Kim, C.-H., Hsueh, K.-C., Billing, C. B., & Williams, K. E. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.06.011 · Cited by 134 · see citing works

Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome

Eisenberg, M. J., Windle, S. B., Roy, N., Old, W. D., Grondin, F. R., Bata, I. R., Iskander, A., Lauzon, C., Srivastava, N. K., Clarke, A., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.019634 · Cited by 133 · see citing works

A preliminary investigation of varenicline for heavy drinking smokers

Fucito, L. M., Toll, B. A., Wu, R., Romano, D. M., Tek, E., & O’Malley, S. S. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2160-9 · Cited by 124 · see citing works

Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.

Tutka, P., & Zatoński, W. A. (2006) · PubMed · Cited by 123 · see citing works

Known and Novel Sources of Variability in the Nicotine Metabolite Ratio in a Large Sample of Treatment-Seeking Smokers

Chenoweth, M. J., Novalen, M., Hawk, L. W., Schnoll, R. A., George, T. P., Cinciripini, P. M., Lerman, C. E., & Tyndale, R. F. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0427 · Cited by 122 · see citing works

Varenicline Versus Bupropion SR or Placebo for Smoking Cessation: A Pooled Analysis

Nides, M. (2008) · American Journal of Health Behavior · doi:10.5993/ajhb.32.6.10 · Cited by 121 · see citing works

Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study

Thomas, K. H., Martin, R. M., Davies, N. M., Metcalfe, C., Windmeijer, F., & Gunnell, D. (2013) · BMJ · doi:10.1136/bmj.f5704 · Cited by 119 · see citing works

Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis

McKee, S. A., Smith, P. H., Kaufman, M., Mazure, C. M., & Weinberger, A. H. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv207 · Cited by 119 · see citing works

Nicotine receptor partial agonists for smoking cessation

Cahill, K., Stead, L. F., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub3 · Cited by 116 · see citing works

Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial

Shim, J.-C., Jung, D.-U., Jung, S. S., Seo, Y.-S., Cho, D.-M., Lee, J.-H., Lee, S.-W., Kong, B.-G., Kang, J.-W., Oh, M., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.238 · Cited by 112 · see citing works

The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial

NIAURA, R. S., Hays, J. T., Jorenby, D. E., Leone, F. T., Pappas, J. E., Reeves, K. R., Williams, K. E., & Billing, C. B. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802177523 · Cited by 112 · see citing works

Effects of Varenicline on Abstinence and Smoking Reward Following a Programmed Lapse

McClure, E. A., Vandrey, R. G., Johnson, M. W., & Stitzer, M. L. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts101 · Cited by 112 · see citing works

Adherence to Varenicline in the COMPASS Smoking Cessation Intervention Trial

Catz, S. L., Jack, L. M., McClure, J. B., Javitz, H. S., Deprey, M., Zbikowski, S. M., McAfee, T. A., Richards, J. A., & Swan, G. E. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr003 · Cited by 111 · see citing works

Smoking at age 18–20 and suicide during 26 years of follow-up—how can the association be explained?

Hemmingsson, T., & Kriebel, D. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg203 · Cited by 111 · see citing works

Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis.

Nides, M. A., Glover, E. D., Reus, V. I., et al. (2009) · PubMed · doi:10.5555/ajhb.2008.32.6.664 · Cited by 110 · see citing works

Advances in pharmacotherapy for tobacco dependence

Foulds, J., Burke, M. V., Steinberg, M. B., Williams, J. M., & Ziedonis, D. M. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/eoed.9.1.39.32951 · Cited by 107 · see citing works

Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study

Kotz, D., Viechtbauer, W., Simpson, C. R., van Schayck, O. C. P., West, R., & Sheikh, A. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00320-3 · Cited by 103 · see citing works

Adherence to treatment for tobacco dependence: Association with smoking abstinence and predictors of adherence

Hays, J. T., Leischow, S. J., Lawrence, D., & Lee, T. C. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq047 · Cited by 100 · see citing works

A Perioperative Smoking Cessation Intervention with Varenicline

Wong, J., Abrishami, A., Yang, Y., Zaki, A., Friedman, Z., Selby, P. L., Chapman, K. R., & Chung, F. F. (2012) · Anesthesiology · doi:10.1097/aln.0b013e3182698b42 · Cited by 99 · see citing works

Varenicline effects on craving, cue reactivity, and smoking reward

Brandon, T. H., Drobes, D. J., Unrod, M., Heckman, B. W., Oliver, J. A., Roetzheim, R. C., Karver, S. B., & Small, B. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2327-z · Cited by 96 · see citing works

Neuropharmacology and potential efficacy of new treatments for tobacco dependence

Fagerström, K. O., & Balfour, D. J. K. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.2.107 · Cited by 95 · see citing works

Varenicline and bupropion sustained-release combination therapy for smoking cessation

Ebbert, J. O., Croghan, I. T., Sood, A., Schroeder, D. R., Hays, J. T., & Hurt, R. D. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntn031 · Cited by 95 · see citing works

Mood, Side-effects and Smoking Outcomes Among Persons With and Without Probable Lifetime Depression Taking Varenicline

McClure, J. B., Swan, G. E., Jack, L. M., Catz, S. L., Zbikowski, S. M., McAfee, T. A., Deprey, M., Richards, J. A., & Javitz, H. S. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0926-8 · Cited by 94 · see citing works

Behavioral Counseling and Varenicline Treatment for Smoking Cessation

Swan, G. E., McClure, J. B., Jack, L. M., Zbikowski, S. M., Javitz, H. S., Catz, S. L., Deprey, M., Richards, J. A., & McAfee, T. A. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.01.024 · Cited by 94 · see citing works

A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates

Rennard, S. I., Hughes, J., Cinciripini, P. M., Králíková, E., Raupach, T., Arteaga, C., Aubin, L. S., Russ, C., & for the Flexible Quit Date Study Group (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr220 · Cited by 92 · see citing works

Cytisine for smoking cessation: A research agenda

Etter, J., Lukas, R. J., Benowitz, N. L., West, R., & Dresler, C. M. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.06.017 · Cited by 90 · see citing works

Use of Varenicline for 4 Weeks Before Quitting Smoking

Hájek, P., McRobbie, H. J., Myers, K., Stapleton, J., & Dhanji, A. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.138 · Cited by 90 · see citing works

Combination Treatment With Varenicline and Bupropion in an Adaptive Smoking Cessation Paradigm

Rose, J. E., & Behm, F. M. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13050595 · Cited by 90 · see citing works

Varenicline for smoking cessation: A placebo‐controlled, randomized study

Wang, C., Xiao, D., Chan, K., Pothirat, C., Garza, D., & DAVIES, S. (2009) · Respirology · doi:10.1111/j.1440-1843.2008.01476.x · Cited by 90 · see citing works

The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta‐analysis*

Etter, J., Burri, M., & Stapleton, J. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01822.x · Cited by 89 · see citing works

A Smoking Cessation Intervention for Thoracic Surgery and Oncology Clinics: A Pilot Trial

Park, E. R., Japuntich, S. J., Temel, J. S., Lanuti, M. D., Pandiscio, J. C., Hilgenberg, J., Davies, D. L., Dresler, C. M., & Rigotti, N. A. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318215a4dc · Cited by 87 · see citing works

Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial

Fagerström, K., Gilljam, H., Metcalfe, M., Tonstad, S., & Messig, M. (2010) · BMJ · doi:10.1136/bmj.c6549 · Cited by 87 · see citing works

Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

Chengappa, K. N. R., Perkins, K. A., Brar, J. S., Schlicht, P. J., Turkin, S. R., Hetrick, M. L., Levine, M. D., & George, T. P. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08756 · Cited by 86 · see citing works

Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes

Slater, Y. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00025-x · Cited by 86 · see citing works

Lobeline for smoking cessation

Stead, L. F., & Hughes, J. R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000124.pub2 · Cited by 81 · see citing works

What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation

Leaviss, J., Sullivan, W., Ren, S., Everson-Hock, E., Stevenson, M., Stevens, J., Strong, M., & Cantrell, A. J. (2014) · Health Technology Assessment · doi:10.3310/hta18330 · Cited by 78 · see citing works

Combination treatment with varenicline and nicotine replacement therapy

Ebbert, J. O., Burke, M. V., Hays, J. T., & Hurt, R. D. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp042 · Cited by 77 · see citing works

Efficacy of the nicotine vaccine 3′‐ AmNic‐rEPA ( NicVAX ) co‐administered with varenicline and counselling for smoking cessation: a randomized placebo‐controlled trial

Hoogsteder, P., Kotz, D., van Spiegel, P. I., Viechtbauer, W., & van Schayck, O. C. P. (2014) · Addiction · doi:10.1111/add.12573 · Cited by 74 · see citing works

Varenicline for smoking cessation among methadone-maintained smokers: A randomized clinical trial

Stein, M. D., Caviness, C. M., Kurth, M. E., Audet, D., Olson, J., & Anderson, B. J. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.005 · Cited by 74 · see citing works

Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors

Hogg, R. C., & Bertrand, D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.010 · Cited by 72 · see citing works

Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study

Kasliwal, R., Wilton, L. V., & Shakir, S. A. W. (2009) · Drug Safety · doi:10.2165/00002018-200932060-00006 · Cited by 71 · see citing works

Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled Trial

Hughes, J. R., Rennard, S. I., Fingar, J. R., Talbot, S., CALLAS, P. W., & Fagerström, K. O. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr103 · Cited by 70 · see citing works

Varenicline and adverse cardiovascular events: a systematic review and meta-analysis of randomized controlled trials.

Sterling, L. H., Windle, S. B., Filion, K. B., Touma, L., & Eisenberg, M. J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002849 · Cited by 70 · see citing works

Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Faessel, H. M., Ravva, P., & Williams, K. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.01.003 · Cited by 69 · see citing works

Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study

Weiner, E., Buchholz, A. S., Coffay, A. O., Liu, F., McMahon, R. P., Buchanan, R. W., & Kelly, D. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.02.003 · Cited by 68 · see citing works

Safety and Tolerability of Varenicline Tartrate (Champix ® /Chantix ® ) for Smoking Cessation in HIV-Infected Subjects: A Pilot Open-Label Study

Cui, Q., Robinson, L. L., Elston, D., Smaill, F., Cohen, J., Quan, C., McFarland, N., Thabane, L., McIvor, A., Zeidler, J. G., et al. (2011) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0199 · Cited by 68 · see citing works

Utilization of Services in a Randomized Trial Testing Phone- and Web-Based Interventions for Smoking Cessation

Zbikowski, S. M., Jack, L. M., McClure, J. B., Deprey, M., Javitz, H. S., McAfee, T. A., Catz, S. L., Richards, J. A., Bush, T. M., & Swan, G. E. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq257 · Cited by 66 · see citing works

The Safety and Efficacy of Varenicline in Cocaine Using Smokers Maintained on Methadone: A Pilot Study

Poling, J. C., Rounsaville, B. J., Gonsai, K., Severino, K., & Sofuoglu, M. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00066.x · Cited by 62 · see citing works

An uncontrolled trial of cytisine (Tabex) for smoking cessation: Table 1

Zatoński, W. A., Cedzyńska, M., Tutka, P., & West, R. (2006) · Tobacco Control · doi:10.1136/tc.2006.016097 · Cited by 62 · see citing works

A pilot test of a combined tobacco dependence treatment and lung cancer screening program

Ferketich, A. K., Otterson, G. A., King, M. A., Hall, N. C., Browning, K. K., & Wewers, M. E. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.10.011 · Cited by 60 · see citing works

The Cost-Effectiveness of an Extended Course (12 + 12 Weeks) of Varenicline Compared with Other Available Smoking Cessation Strategies in the United States: An Extension and Update to the BENESCO Model

Knight, C., Howard, P., Baker, C. L., & Marton, J. P. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00672.x · Cited by 59 · see citing works

Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial

Hájek, P., Smith, K. M., Dhanji, A., & McRobbie, H. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-140 · Cited by 58 · see citing works

Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients

Tashkin, D. P., Rennard, S. I., Hays, J. T., Lawrence, D., Márton, J., & Lee, T. C. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.04.016 · Cited by 58 · see citing works

Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week Open-Label Trial

Pachas, G. N., Cather, C., Pratt, S. I., Hoeppner, B. B., Nino, J., Carlini, S. V., Achtyes, E. D., Lando, H. A., Mueser, K. T., Rigotti, N. A., et al. (2012) · Journal of Dual Diagnosis · doi:10.1080/15504263.2012.663675 · Cited by 58 · see citing works

Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial

Jennings, C. S., Kotseva, K., Bacquer, D. D., Hoes, A. W., Velasco, J. D., Brusaferro, S., Mead, A., Jones, J. L., Tonstad, S., Wood, D., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu051 · Cited by 58 · see citing works

Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation

Ramon, J. M., Morchón, S., Baena, A., & Aumatell, C. M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0172-8 · Cited by 57 · see citing works

Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study

Bolliger, C. T., Issa, J. S., Posadas-Valay, R., Safwat, T., Abreu, P. C., Correia, E. A., Park, P. W., & Chopra, P. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.04.013 · Cited by 55 · see citing works

Psychiatric Adverse Events Associated with Varenicline: An Intensive Postmarketing Prospective Cohort Study in New Zealand

Harrison-Woolrych, M., & Ashton, J. (2011) · Drug Safety · doi:10.2165/11594450-000000000-00000 · Cited by 54 · see citing works

Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study

Molero, Y., Lichtenstein, P., Zetterqvist, J., Gumpert, C. H., & Fazel, S. (2015) · BMJ · doi:10.1136/bmj.h2388 · Cited by 54 · see citing works

Varenicline versus Bupropion XL for Smoking Cessation in Older Adolescents: A Randomized, Double-Blind Pilot Trial

Gray, K. M., Carpenter, M. J., Lewis, A. L., Klintworth, E., & Upadhyaya, H. P. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr130 · Cited by 53 · see citing works

Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment

Hájek, P., Tønnesen, P., Arteaga, C., Russ, C., & Tonstad, S. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02646.x · Cited by 53 · see citing works

Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting

Halperin, A. C., McAfee, T. A., Jack, L. M., Catz, S. L., McClure, J. B., Deprey, T. M., Richards, J. A., Zbikowski, S. M., & Swan, G. E. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.09.001 · Cited by 53 · see citing works

Interventions for smokeless tobacco use cessation

Ebbert, J. O., Montori, V. M., Erwin, P. J., & Stead, L. F. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004306.pub4 · Cited by 53 · see citing works

Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

Burstein, A. H., Fullerton, T., Clark, D. J., & Faessel, H. M. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006291837 · Cited by 52 · see citing works

Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study

Svanström, H., Pasternak, B., & Hviid, A. P. (2012) · BMJ · doi:10.1136/bmj.e7176 · Cited by 52 · see citing works

Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial

Gonzales, D. H., Hájek, P., Pliamm, L., Nackaerts, K., Tseng, L.-J., McRae, T. D., & Treadow, J. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.124 · Cited by 52 · see citing works

Adapting Smoking Cessation Treatment According to Initial Response to Precessation Nicotine Patch

Rose, J. E., & Behm, F. M. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12070919 · Cited by 51 · see citing works

A Double-Blind, Randomised, Placebo-Controlled Trial of Cytisine for Smoking Cessation in Medium-Dependent Workers

Vinnikov, D. V., Brimkulov, N. N., & Burjubaeva, A. (2008) · The Journal of Smoking Cessation · doi:10.1375/jsc.3.1.57 · Cited by 50 · see citing works

A Double-Blind Randomized Placebo-Controlled Pilot Study of Neuropsychiatric Adverse Events in Abstinent Smokers Treated with Varenicline or Placebo

Garza, D., Murphy, M. F., Tseng, L., Riordan, H., & Chatterjee, A. K. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.005 · Cited by 50 · see citing works

A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study)

Tsukahara, H., Noda, K., & Saku, K. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0803 · Cited by 50 · see citing works

Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial

Nahvi, S., Ning, Y. M., Segal, K. S., Richter, K. P., & Arnsten, J. H. (2014) · Addiction · doi:10.1111/add.12631 · Cited by 50 · see citing works

Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011

Thomas, K. H., Martin, R. M., Potokar, J. P., Pirmohamed, M., & Gunnell, D. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-54 · Cited by 50 · see citing works

Project Impact: A pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers

de Dios, M. A., Anderson, B. J., Stanton, C. A., Audet, D., & Stein, M. D. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2012.01.004 · Cited by 49 · see citing works

Smoking outcome by psychiatric history after behavioral and varenicline treatment

McClure, J. B., Swan, G. E., Catz, S. L., Jack, L. M., Javitz, H. S., McAfee, T. A., Deprey, M., Richards, J. A., & Zbikowski, S. M. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.03.007 · Cited by 47 · see citing works

Neuropsychiatric events in varenicline and nicotine replacement patch users in the M ilitary H ealth S ystem

Meyer, T. E., Taylor, L. G., Xie, S., Graham, D. J., Mosholder, A. D., Williams, J. R., Moeny, D. G., Ouellet‐Hellstrom, R., & Coster, T. S. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04024.x · Cited by 45 · see citing works

The Effects of Extended Pre-Quit Varenicline Treatment on Smoking Behavior and Short-Term Abstinence: A Randomized Clinical Trial

Hawk, L. W., Ashare, R. L., Lohnes, S. F., Schlienz, N. J., Rhodes, J. D., Tiffany, S. T., Gass, J. C., Cummings, K. M., & Mahoney, M. C. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.317 · Cited by 45 · see citing works

Safety of Varenicline Among Smokers Enrolled in the Lung HIV Study

Ferketich, A. K., Diaz, P., Browning, K. K., Lu, B., Koletar, S. L., Reynolds, N. R., & Wewers, M. E. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts121 · Cited by 44 · see citing works

Cardiovascular Safety of Varenicline

Ware, J. H., Vetrovec, G. W., Miller, A. B., Tosh, A. V., Gaffney, M., Yunis, C., Arteaga, C., & BORER, J. S. (2013) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31828d455b · Cited by 44 · see citing works

An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation

Jackson, K. C., Nahoopii, R., Said, Q., Dirani, R. D., & Brixner, D. I. (2007) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3180459ff2 · Cited by 43 · see citing works

A Pilot Clinical Trial of Varenicline for Smoking Cessation in Black Smokers

Nollen, N. L., Cox, L. S., Nazir, N., Ellerbeck, E. F., Owen, A., Pankey, S., Thompson, N. J., & Ahluwalia, J. S. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr063 · Cited by 42 · see citing works

The effect of smoking cessation on airway inflammation in young asthma patients

Westergaard, C. G., Porsbjerg, C. M., & Backer, V. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12243 · Cited by 40 · see citing works

Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers

McColl, S. L., Burstein, A., Reeves, K. R., Billing, C., Stolar, M. J., & Sellers, E. M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100510 · Cited by 40 · see citing works

Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity

Dutra, S. J., Stoeckel, L. E., Carlini, S. V., Pizzagalli, D. A., & Evins, A. E. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2373-6 · Cited by 40 · see citing works

Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran

Heydari, G., Talischi, F., Tafti, S. F., & Masjedi, M. R. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.11.0183 · Cited by 40 · see citing works

Strategies for Quantifying the Relationship between Medications and Suicidal Behaviour

Gibbons, R. D., & Mann, J. J. (2011) · Drug Safety · doi:10.2165/11589350-000000000-00000 · Cited by 39 · see citing works

Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo

Gonzales, D., Jorenby, D. E., Brandon, T. H., Arteaga, C., & Lee, T. C. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03058.x · Cited by 37 · see citing works

Effects of Short-Term Varenicline Administration on Emotional and Cognitive Processing in Healthy, Non-Smoking Adults: A Randomized, Double-Blind, Study

Mocking, R. J. T., Pflanz, C. P., Pringle, A., Parsons, E., McTavish, S. F. B., Cowen, P. J., & Harmer, C. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.205 · Cited by 37 · see citing works

Tobacco dependence treatment for hospitalized smokers: A randomized, controlled, pilot trial using varenicline

Steinberg, M. B., Randall, J., Greenhaus, S., Schmelzer, A. C., Richardson, D. L., & Carson, J. L. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.07.002 · Cited by 37 · see citing works

A Double-Blind Placebo-Controlled Randomized Trial of Varenicline for Smokeless Tobacco Dependence in India

Jain, R., Jhanjee, S., Jain, V., Gupta, T., Mittal, S., Goelz, P. M., Wileyto, E. P., & Schnoll, R. A. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntt115 · Cited by 36 · see citing works

Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances

Uhl, G. R., Walther, D. M., Musci, R. J., Fisher, C., Anthony, J. C., Storr, C. L., Behm, F. M., Eaton, W. W., Ialongo, N. S., & Rose, J. E. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.155 · Cited by 35 · see citing works

Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan

Igarashi, A., Takuma, H., Fukuda, T., & Tsutani, K. (2009) · PharmacoEconomics · doi:10.2165/00019053-200927030-00007 · Cited by 35 · see citing works

A Longer Course of Varenicline Therapy Improves Smoking Cessation Rates

Lee, J. H., Jones, P. G., Bybee, K., & O’Keefe, J. H. (2008) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.00003.x · Cited by 34 · see citing works

[Cytisine (Tabex) as a pharmaceutical aid in stopping smoking].

Scharfenberg, G., Benndorf, S., & Kempe, G. (1971) · PubMed · Cited by 34 · see citing works

Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries

Fagerström, K. O., Nakamura, M., Cho, H., Tsai, S.-T., Wang, C., Davies, S., Ma, W., Lee, T. C., & Russ, C. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.505130 · Cited by 33 · see citing works

The effect of Varenicline on smoking cessation in a group of young asthma patients

Westergaard, C. G., Porsbjerg, C. M., & Backer, V. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.07.017 · Cited by 32 · see citing works

Use of knock-out mice to determine the molecular basis for the actions of nicotine

Picciotto, M. R., Zoli, M., & Changeux, J. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011931 · Cited by 32 · see citing works

Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: A double-blind placebo and bupropion-controlled study

Fatemi, S. H., Yousefi, M. K., Kneeland, R. E., Liesch, S. B., Folsom, T. D., & THURAS, P. D. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.015 · Cited by 32 · see citing works

Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation

Tutka, P. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.10.1473 · Cited by 32 · see citing works

Lobeline for smoking cessation

Stead, L. F., & Hughes, J. R. (1997) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000124 · Cited by 32 · see citing works

Smoking Termination Opportunity for inPatients (STOP): superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 12-month randomised controlled trial for inpatients

Smith, B. J., Carson‐Chahhoud, K., Brinn, M. P., Labiszewski, N. A., Peters, M. J., Fitridge, R., Koblar, S. A., Jannes, J., Veale, A., Goldsworthy, S. J., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202484 · Cited by 31 · see citing works

Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis

Leung, L. K., Patafio, F., & Rosser, W. (2011) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-11-15 · Cited by 31 · see citing works

Adverse Effects Cause Varenicline Discontinuation: A Meta-Analysis

Drovandi, A. D., Chen, C. C. M., & Glass, B. D. (2015) · Current Drug Safety · doi:10.2174/1574886311207040282 · Cited by 30 · see citing works

Cardiovascular Events in Patients taking Varenicline

Harrison‐Woolrych, M., Maggo, S. D. S., Tan, M., Savage, R. L., & Ashton, J. (2011) · Drug Safety · doi:10.2165/11597690-000000000-00000 · Cited by 29 · see citing works

The impact of pre-cessation varenicline on behavioral economic indices of smoking reinforcement

Schlienz, N. J., Hawk, L. W., Tiffany, S. T., O’Connor, R. J., & Mahoney, M. C. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.05.008 · Cited by 29 · see citing works

Smoking‐cessation therapy using varenicline: the cost‐utility of an additional 12‐week course of varenicline for the maintenance of smoking abstinence

Bolin, K., Mörk, A., & Wilson, K. (2009) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01045.x · Cited by 29 · see citing works

A Pilot Study of the Efficacy of Varenicline for the Treatment of Smokeless Tobacco Users in Midwestern United States

Ebbert, J. O., Croghan, I. T., Severson, H. H., Schroeder, D. R., & Hays, J. T. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr078 · Cited by 29 · see citing works

Predictors of post-treatment relapse to smoking in successful quitters: Pooled data from two phase III varenicline trials

Heffner, J. L., Lee, T. C., Arteaga, C., & Anthenelli, R. M. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.022 · Cited by 27 · see citing works

Dianicline, a Novel 4 2 Nicotinic Acetylcholine Receptor Partial Agonist, for Smoking Cessation: A Randomized Placebo-Controlled Clinical Trial

Tonstad, S., Holme, I., & Tønnesen, P. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq191 · Cited by 25 · see citing works

Quantitative Assessment of Exposure–Response Relationships for the Efficacy and Tolerability of Varenicline for Smoking Cessation

Ravva, P., Gastonguay, M. R., French, J. L., Tensfeldt, T. G., & Faessel, H. M. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.282 · Cited by 24 · see citing works

Adherence to Varenicline Among African American Smokers: An Exploratory Analysis Comparing Plasma Concentration, Pill Count, and Self-report

Scheuermann, T. S., Berg, C. J., Cox, L. S., Nazir, N., Benowitz, N. L., Yu, L., Yturralde, O., Jacob, P., Choi, W. S., Ahluwalia, J. S., et al. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr333 · Cited by 24 · see citing works

Increasing Varenicline Dose in Smokers Who Do Not Respond to the Standard Dosage

Hájek, P., McRobbie, H. J., Smith, K., Phillips, A. C., Cornwall, D., & Dhanji, A. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6916 · Cited by 23 · see citing works

Discontinued psychiatric drugs in 2008

Kirchhoff, V., Nguyen, H. T., Soczynska, J. K., Woldeyohannes, H. O., & McIntyre, R. S. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903184591 · Cited by 22 · see citing works

Increasing the Dose of Varenicline in Patients Who Do Not Respond to the Standard Dose

Jimenez-Ruiz, C. A., Barrios, M., Peña, S., Cicero, A., Mayayo, M. P. M., Fernández, M. C., & Perera, L. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.08.015 · Cited by 22 · see citing works

A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data

Xenakis, J. G., Kinter, E. T., Ishak, K. J., Ward, A. J., Marton, J. P., Willke, R. J., Davies, S., & Jaime, J. (2011) · PharmacoEconomics · doi:10.2165/11589230-000000000-00000 · Cited by 21 · see citing works

Predictors of Lapse and Relapse to Smoking in Successful Quitters in a Varenicline Post Hoc Analysis in Japanese Smokers

Nakamura, M., Oshima, A., Ohkura, M., Arteaga, C., & Suwa, K. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.03.013 · Cited by 21 · see citing works

Varenicline for Smoking Cessation in Patients With Coronary Heart Disease

Ockene, I. S., & Salmoirago‐Blotcher, E. (2010) · Circulation · doi:10.1161/circulationaha.109.915546 · Cited by 21 · see citing works

Cytisine's Potential to Be Used as a Traditional Healing Method to Help Indigenous People Stop Smoking: A Qualitative Study With M ori

Thompson-Evans, T. P., Glover, M., & Walker, N. K. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr002 · Cited by 20 · see citing works

Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan

Hsueh, K.-C., Hsueh, S.-C., Chou, M.-Y., Pan, L.-F., Tu, M., McEwen, A., & West, R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3482-9 · Cited by 20 · see citing works

Varenicline to Stop Long-term Nicotine Replacement Use: A Double-Blind, Randomized, Placebo-Controlled Trial

Tønnesen, P., & Mikkelsen, K. L. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts146 · Cited by 20 · see citing works

Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers

Roche, D. J. O., Bujarski, S., Hartwell, E. E., Green, R., & Ray, L. A. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.04.013 · Cited by 19 · see citing works

Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking

Walker, N. K., Howe, C., Bullen, C., McRobbie, H. J., Glover, M., Parag, V., Williman, J. A., Veale, R., Nosa, V. H., & Barnes, J. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-880 · Cited by 18 · see citing works

A pilot study to assess smokeless tobacco use reduction with varenicline

Ebbert, J. O., Croghan, I. T., North, F., & Schroeder, D. R. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq134 · Cited by 18 · see citing works

Early Quit Days Among Methadone-Maintained Smokers in a Smoking Cessation Trial

de Dios, M. A., Anderson, B. J., Caviness, C. M., & Stein, M. D. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu099 · Cited by 18 · see citing works

Pilot Randomized Trial of an Automated Smoking Cessation Intervention via Mobile Phone Text Messages as an Adjunct to Varenicline in Primary Care

Yingst, J. M., Veldheer, S., Hrabovsky, S., Hammett, E., Nicholson, J. M., Berg, A. S., & Foulds, J. (2018) · Journal of Health Communication · doi:10.1080/10810730.2018.1453890 · Cited by 18 · see citing works

Internet Versus In-Person Counseling for Patients Taking Varenicline for Smoking Cessation

DeZee, K. J., Wink, J. S., & Cowan, C. M. (2013) · Military Medicine · doi:10.7205/milmed-d-12-00272 · Cited by 17 · see citing works

Mouse model predicts effects of smoking and varenicline on event-related potentials in humans

Rudnick, N. D., Strasser, A. A., Phillips, J. M., Jepson, C., Patterson, F., Frey, J. M., Turetsky, B. I., Lerman, C. E., & Siegel, S. J. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq049 · Cited by 17 · see citing works

A Feasibility Study of Varenicline for Smoking Cessation in Bipolar Patients With Subsyndromal Depression

Frye, M. A., Ebbert, J. O., Prince, C. A., Lineberry, T. W., Geske, J. R., & Patten, C. A. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31829cc3cd · Cited by 17 · see citing works

Combining intensive practice nurse counselling or brief general practitioner advice with varenicline for smoking cessation in primary care: Study protocol of a pragmatic randomized controlled trial

van Rossem, C., Spigt, M., Smit, E. S., Viechtbauer, W., Mijnheer, K., van Schayck, O. C. P., & Kotz, D. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.01.017 · Cited by 16 · see citing works

Extended interactive voice response telephony (IVR) for relapse prevention after smoking cessation using varenicline and IVR: a pilot study

McNaughton, B., Frohlich, J., Graham, A., & Young, Q. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-824 · Cited by 16 · see citing works

A Novel Recruitment Message to Increase Enrollment Into a Smoking Cessation Treatment Program: Preliminary Results From a Randomized Trial

Schnoll, R. A., Cappella, J. N., Lerman, C. E., Pinto, A. G., Patterson, F., Wileyto, E. P., Bigman, C. A., & Leone, F. T. (2011) · Health Communication · doi:10.1080/10410236.2011.566829 · Cited by 15 · see citing works

Safety of Varenicline Tartrate and Counseling Versus Counseling Alone for Smoking Cessation: A Randomized Controlled Trial for Inpatients (STOP Study)

Carson‐Chahhoud, K., Smith, B. J., Brinn, M. P., Peters, M. J., Fitridge, R., Koblar, S. A., Jannes, J., Singh, K., Veale, A., Goldsworthy, S. J., et al. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu112 · Cited by 15 · see citing works

Cytisine versus Nicotine for Smoking Cessation

Zatoński, W. A., & Zatonski, M. Z. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1500342 · Cited by 15 · see citing works

[Results of clinical investigation of anti-nicotine drug patches].

Tp, O. (1994) · PubMed · Cited by 15 · see citing works

A randomized controlled trial of the efficacy and safety of varenicline for smoking cessation after acute coronary syndrome: Design and methods of the Evaluation of Varenicline in Smoking Cessation for Patients Post-Acute Coronary Syndrome trial

Windle, S. B., Bata, I. R., Madan, M., Abramson, B. L., & Eisenberg, M. J. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.010 · Cited by 14 · see citing works

Smoking Is a Disease and Smokers Are Patients

Fujiwara, H. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0165 · Cited by 14 · see citing works

Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: A cross-study analysis

Hughes, J. R., Russ, C., Arteaga, C. E. Q., & Rennard, S. I. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.08.001 · Cited by 14 · see citing works

Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: Rationale, methods and participant characteristics of the FLEX trial

Tulloch, H. E., Pipe, A., Els, C., Aitken, D., Clyde, M. J., Corran, B., & Reid, R. D. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.05.011 · Cited by 14 · see citing works

The place of varenicline in smoking cessation treatment

Aveyard, P. N. (2008) · Thorax · doi:10.1136/thx.2008.096081 · Cited by 13 · see citing works

[Medical support of nicotine withdrawal. Report on a double blind trail in over 5000 smokers (author's transl)].

Schmidt, F. (1974) · PubMed · Cited by 13 · see citing works

AUSTRALIA'S EXPERIENCE WITH VARENICLINE: USAGE, COSTS AND ADVERSE REACTIONS

Walsh, R. A. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03282.x · Cited by 12 · see citing works

Comment and Reply: A double-blind study evaluating the long-term safety of varenicline for smoking cessation

Spangler, J. G., Williamsa, K. E., Reeves, K. R., Billing, C., PENNINGTON, A., & Gong, J. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x261140 · Cited by 12 · see citing works

Examination of the mechanism of action of two pre-quit pharmacotherapies for smoking cessation

Ferguson, S. G., Walters, J. A., Lu, W., Wells, G., & Schüz, N. (2015) · BMC Public Health · doi:10.1186/s12889-015-2596-2 · Cited by 12 · see citing works

PSM3 AN EVALUATION OF THE COST-EFFECTIVENESS OF AN EXTENDED COURSE OF VARENICLINE IN PREVENTING SMOKERS WHO HAVE QUIT FROM RELAPSING

Knight, C. R., Howard, P., & Baker, C. (2007) · Value in Health · doi:10.1016/s1098-3015(10)65622-7 · Cited by 11 · see citing works

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485 · see citing works

2023 ESC Guidelines for the management of acute coronary syndromes

Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333 · see citing works

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization

Lawton, J. S., Tamis‐Holland, J. E., Bangalore, S., Bates, E., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,651 · see citing works

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology joint committee on clinical practice guidelines

Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598 · see citing works

Electronic cigarettes for smoking cessation

Hartmann‐Boyce, J., McRobbie, H. J., Bullen, C., Begh, R. A., Stead, L. F., & Hájek, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub3 · Cited by 1,217 · see citing works

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works

Nicotine replacement therapy versus control for smoking cessation

Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub5 · Cited by 697 · see citing works

Tobacco smoking: health impact, prevalence, correlates and interventions

West, R. (2017) · Psychology & Health · doi:10.1080/08870446.2017.1325890 · Cited by 694 · see citing works

Systematic integration of biomedical knowledge prioritizes drugs for repurposing

Himmelstein, D. S., Lizee, A., Hessler, C., Brueggeman, L., Chen, S. L., Hadley, D., Green, A., Khankhanian, P., & Baranzini, S. E. (2017) · eLife · doi:10.7554/elife.26726 · Cited by 666 · see citing works

Psychosocial interventions for supporting women to stop smoking in pregnancy

Chamberlain, C., O'Mara-Eves, A., Porter, J., Coleman, T., Perlen, S. M., Thomas, J., & McKenzie, J. E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub5 · Cited by 650 · see citing works

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease

Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596 · see citing works

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab154 · Cited by 565 · see citing works

Weight gain in smokers after quitting cigarettes: meta-analysis

Aubin, H.-J., Farley, A., Lycett, D., Lahmek, P., & Aveyard, P. (2012) · BMJ · doi:10.1136/bmj.e4439 · Cited by 510 · see citing works

Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force, Krist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Donahue, K., Doubeni, C. A., Epling, J. W., et al. (2021) · JAMA · doi:10.1001/jama.2020.25019 · Cited by 512 · see citing works

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention

Volkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503 · see citing works

Smoking and the risk of type 2 diabetes

Maddatu, J., Anderson‐Baucum, E. K., & Evans‐Molina, C. (2017) · Translational research · doi:10.1016/j.trsl.2017.02.004 · Cited by 403 · see citing works

Antidepressants for smoking cessation

Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352 · see citing works

Treatment of Tobacco Smoking: A Review

Rigotti, N. A., Kruse, G. R., Livingstone-Banks, J., & Hartmann-Boyce, J. (2022) · JAMA · doi:10.1001/jama.2022.0395 · Cited by 361 · see citing works

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment

Barua, R. S., Rigotti, N. A., Benowitz, N. L., Cummings, K. M., Jazayeri, M., Morris, P. B., Ratchford, E. V., Sarna, L., Stecker, E. C., & Wiggins, B. S. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.027 · Cited by 377 · see citing works

Electronic cigarettes for smoking cessation

Hartmann‐Boyce, J., McRobbie, H. J., Lindson, N., Bullen, C., Begh, R., Theodoulou, A., Notley, C. J., Rigotti, N. A., Turner, T., Butler, A. R., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub4 · Cited by 333 · see citing works

Electronic cigarettes for smoking cessation

Hartmann-Boyce, J., Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub7 · Cited by 320 · see citing works

2023 ESC Guidelines for the management of acute coronary syndromes

Byrne, R. A., Rosselló, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 341 · see citing works

Electronic cigarettes for smoking cessation

Hartmann‐Boyce, J., McRobbie, H. J., Butler, A. R., Lindson, N., Bullen, C., Begh, R. A., Theodoulou, A., Notley, C. J., Rigotti, N. A., Turner, T., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub5 · Cited by 314 · see citing works

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 317 · see citing works

Interventions to reduce harm from continued tobacco use

Lindson, N., Hartmann‐Boyce, J., Fanshawe, T. R., Begh, R. A., Farley, A., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005231.pub3 · Cited by 271 · see citing works

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation

Lindson, N., Chepkin, S. C., Ye, W., Fanshawe, T. R., Bullen, C., & Hartmann-Boyce, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013308 · Cited by 254 · see citing works

Peripheral artery disease

Morley, R., Sharma, A. K., Horsch, A. D., & Hinchliffe, R. J. (2018) · BMJ · doi:10.1136/bmj.j5842 · Cited by 239 · see citing works

Interventions for Tobacco Cessation in Adults, Including Pregnant Persons

Patnode, C. D., Henderson, J. T., Coppola, E. L., Melnikow, J., Durbin, S., & Thomas, R. G. (2021) · JAMA · doi:10.1001/jama.2020.23541 · Cited by 212 · see citing works

Non–Small Cell Lung Cancer, Version 1.2015

Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D’Amico, T. A., Demmy, T. L., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0176 · Cited by 212 · see citing works

Pharmacological interventions for promoting smoking cessation during pregnancy

Claire, R., Chamberlain, C., Davey, M.-A., Cooper, S. E., Berlin, I., Leonardi-Bee, J., & Coleman, T. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010078.pub3 · Cited by 188 · see citing works

Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation

Hartmann-Boyce, J., Hong, B., Livingstone-Banks, J., Wheat, H., & Fanshawe, T. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009670.pub4 · Cited by 186 · see citing works

Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses

Lindson, N., Theodoulou, A., Ordóñez-Mena, J. M., Fanshawe, T. R., Sutton, A. J., Livingstone‐Banks, J., Hajizadeh, A., Zhu, S., Aveyard, P. N., Freeman, S. C., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015226.pub2 · Cited by 189 · see citing works

Clinical Effects of Cigarette Smoking: Epidemiologic Impact and Review of Pharmacotherapy Options

Onor, I. O., Stirling, D., Williams, S. R., Bediako, D., Borghol, A., Harris, M. B., Darensburg, T. B., Clay, S. D., Okpechi, S. C., & Sarpong, D. F. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14101147 · Cited by 173 · see citing works

Electronic cigarettes for smoking cessation

Hartmann‐Boyce, J., McRobbie, H. J., Butler, A. R., Lindson, N., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub6 · Cited by 175 · see citing works

Nursing interventions for smoking cessation

Rice, V. H., Heath, L., Livingstone‐Banks, J., & Hartmann‐Boyce, J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001188.pub5 · Cited by 166 · see citing works

Comparison of Treatments for Cocaine Use Disorder Among Adults: A Systematic Review and Meta-analysis

Bentzley, B. S., Han, S. S., Neuner, S., Humphreys, K., Kampman, K. M., & Halpern, C. H. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8049 · Cited by 161 · see citing works

Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis

Thomas, K. H., Dalili, M. N., López-López, J. A., Keeney, E., Phillippo, D., Munafo, M. R., Stevenson, M., Caldwell, D. M., & Welton, N. J. (2021) · Health Technology Assessment · doi:10.3310/hta25590 · Cited by 153 · see citing works

The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex

Ceceli, A. O., Bradberry, C. W., & Goldstein, R. Z. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01153-9 · Cited by 150 · see citing works

2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines

Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. M., Викторович, А. М., Alexandrova, L. M., Анциферова, А. А., Dm, A., Ахмеджанов, Н. М., Balanova, Y. А., et al. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3235 · Cited by 172 · see citing works

Heated tobacco products for smoking cessation and reducing smoking prevalence

Tattan‐Birch, H., Hartmann‐Boyce, J., Kock, L. S., Simonavicius, E., Brose, L. S., Jackson, S. E., Shahab, L., & Brown, J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013790.pub2 · Cited by 137 · see citing works

Nicotinic acetylcholine receptors in neuropathic and inflammatory pain

Hone, A. J., & McIntosh, J. M. (2017) · FEBS Letters · doi:10.1002/1873-3468.12884 · Cited by 134 · see citing works

Smoking reduction interventions for smoking cessation

Lindson, N., Klemperer, E., Hong, B., Ordóñez-Mena, J. M., & Aveyard, P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013183.pub2 · Cited by 133 · see citing works

Tobacco use and cessation for cancer survivors: An overview for clinicians

Karam‐Hage, M., Cinciripini, P. M., & Gritz, E. R. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21231 · Cited by 122 · see citing works

Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence

Xiao, C., Zhou, C., Jiang, J., & Cui, Y. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0299-4 · Cited by 120 · see citing works

Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease

Abramson, B. L., Al-Omran, M. A., Anand, S. S., Albalawi, Z., Coutinho, T. A., de Mestral, C., Dubois, L. A., Gill, H. L., Greco, E., Guzman, R., et al. (2022) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2022.02.029 · Cited by 124 · see citing works

Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial

Courtney, R. J., McRobbie, H., Tutka, P., Weaver, N. A., Petrie, D., Mendelsohn, C. P., Shakeshaft, A., Talukder, S., Macdonald, C., Thomas, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.7621 · Cited by 118 · see citing works

Electronic cigarettes for smoking cessation.

(2012) · PubMed · Cited by 115 · see citing works

Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal

Hindocha, C., Freeman, T. P., Grabski, M., Stroud, J., Crudgington, H., Davies, A. C., Das, R., Lawn, W., Morgan, C. J. A., & Curran, H. V. (2018) · Addiction · doi:10.1111/add.14243 · Cited by 107 · see citing works

Nicotine receptor partial agonists for smoking cessation

Livingstone‐Banks, J., Fanshawe, T. R., Thomas, K. H., Theodoulou, A., Hajizadeh, A., Hartman, L., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub8 · Cited by 106 · see citing works

What phytotherapy needs: Evidence‐based guidelines for better clinical practice

Colalto, C. (2017) · Phytotherapy Research · doi:10.1002/ptr.5977 · Cited by 98 · see citing works

Prevention and Treatment of Tobacco Use

Kalkhoran, S. M., Benowitz, N. L., & Rigotti, N. A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.036 · Cited by 96 · see citing works

Interventions for preventing weight gain after smoking cessation

Hartmann‐Boyce, J., Theodoulou, A., Farley, A., Hájek, P., Lycett, D., Jones, L. L., Kudlek, L., Heath, L., Hajizadeh, A., Schenkels, M., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006219.pub4 · Cited by 96 · see citing works

Relapse prevention interventions for smoking cessation

Livingstone-Banks, J., Norris, E., Hartmann-Boyce, J., West, R., Jarvis, M., & Hajek, P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003999.pub5 · Cited by 94 · see citing works

Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking

O’Malley, S. S., Zweben, A., Fucito, L. M., Wu, R., Piepmeier, M. E., Ockert, D. M., Bold, K. W., Petrakis, I. L., Muvvala, S. B., Jatlow, P. I., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3544 · Cited by 94 · see citing works

Discovery and development of varenicline for smoking cessation

Jordan, C. J., & Xi, Z. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1458090 · Cited by 90 · see citing works

The endocannabinoid system as a target for addiction treatment: Trials and tribulations

Sloan, M. E., Gowin, J. L., Ramchandani, V. A., Hurd, Y. L., & Foll, B. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.031 · Cited by 90 · see citing works

Smoking cessation in pregnancy: a continuing challenge in the United States

Scherman, A. J., Tolosa, J. E., & McEvoy, C. T. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618775366 · Cited by 85 · see citing works

Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial

Lengsfeld, S., Burkard, T., Meienberg, A., Jeanloz, N., Vukajlovic, T., Bologna, K., Steinmetz, M., Bathelt, C., Sailer, C. O., Vogt, D., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101865 · Cited by 89 · see citing works

Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica

Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J. M., Capodanno, D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.016 · Cited by 80 · see citing works

Relapse prevention interventions for smoking cessation

Livingstone-Banks, J., Norris, E., Hartmann-Boyce, J., West, R., Jarvis, M., Chubb, E., & Hajek, P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003999.pub6 · Cited by 77 · see citing works

Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial

Walker, N. K., Smith, B. D., Barnes, J., Verbiest, M. E. A., Parag, V., Pokhrel, S., Wharakura, M., Lees, T., Gutierrez, H. C., Jones, B., et al. (2021) · Addiction · doi:10.1111/add.15489 · Cited by 75 · see citing works

Cytisine and cytisine derivatives. More than smoking cessation aids

Gotti, C., & Clementi, F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105700 · Cited by 75 · see citing works

Barriers and Facilitators of Adherence to Nicotine Replacement Therapy: A Systematic Review and Analysis Using the Capability, Opportunity, Motivation, and Behaviour (COM-B) Model

Mersha, A. G., Gould, G. S., Bovill, M., & Eftekhari, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238895 · Cited by 73 · see citing works

Electronic cigarettes and thirdhand tobacco smoke: two emerging health care challenges for the primary care provider

Kuschner, W. G., Reddy, Mehrotra, N., Paintal, Reddy, S., & Mehrotra, N. (2011) · International Journal of General Medicine · doi:10.2147/ijgm.s16908 · Cited by 73 · see citing works

Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking

Gómez‐Coronado, N., Walker, A. J., Berk, M., & Dodd, S. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2073 · Cited by 71 · see citing works

2024 Clinical practice guidelines for Acute myocardial infarction with ST segment elevation electrocardiogram

Валерьевич, А. О., HARUTYUNYAN, G., Duplyakov, D. V., Константинова, Е. В., Konstantinova, N. N., Shakhnovich, R. M., Yavelov, I. S., Yakovlev, A. N., Sa, A., Alekyan, B. G., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6306 · Cited by 82 · see citing works

Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study

Cadham, C. J., Cao, P., Jayasekera, J. C., Taylor, K. L., Levy, D. T., Jeon, J., Elkin, E. B., Foley, K. L., Joseph, A. M., Kong, C. Y., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab002 · Cited by 70 · see citing works

Nicotine receptor partial agonists for smoking cessation

Livingstone‐Banks, J., Fanshawe, T. R., Thomas, K. H., Theodoulou, A., Hajizadeh, A., Hartman, L., & Lindson, N. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub9 · Cited by 71 · see citing works

National Trends in Cessation Counseling, Prescription Medication Use, and Associated Costs Among US Adult Cigarette Smokers

Tibuakuu, M., Okunrintemi, V., Jirru, E., Echouffo-Tcheugui, J. B., Orimoloye, O. A., Mehta, P. K., DeFilippis, A. P., Blaha, M. J., & Michos, E. D. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.4585 · Cited by 66 · see citing works

Effects of varenicline on subjective craving and relative reinforcing value of cigarettes

Green, R., & Ray, L. A. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.03.037 · Cited by 65 · see citing works

Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation

Jackson, S. E., McGowan, J., Ubhi, H. K., Proudfoot, H., Shahab, L., Brown, J., & West, R. (2019) · Addiction · doi:10.1111/add.14549 · Cited by 64 · see citing works

A Mobile Health Solution Complementing Psychopharmacology-Supported Smoking Cessation: Randomized Controlled Trial

Carrasco-Hernandez, L., Jódar-Sánchez, F., Núñez-Benjumea, F., Moreno Conde, J., Mesa González, M., Civit-Balcells, A., Hors-Fraile, S., Parra-Calderón, C. L., Bamidis, P. D., & Ortega-Ruiz, F. (2020) · JMIR mHealth and uHealth · doi:10.2196/17530 · Cited by 65 · see citing works

Study protocol of the German Study on Tobacco Use (DEBRA): a national household survey of smoking behaviour and cessation

Kastaun, S., Brown, J., Brose, L. S., Ratschen, E., Raupach, T., Nowak, D., Cholmakow-Bodechtel, C., Shahab, L., West, R., & Kotz, D. (2017) · BMC Public Health · doi:10.1186/s12889-017-4328-2 · Cited by 64 · see citing works

Smoking cessation and response to periodontal treatment

Alexandridi, F., Tsantila, S., & Pepelassi, E. (2017) · Australian Dental Journal · doi:10.1111/adj.12568 · Cited by 59 · see citing works

Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders

Das, S., & Prochaska, J. J. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1361823 · Cited by 59 · see citing works

Tobacco use during pregnancy

Havard, A., Chandran, J. J., & Oei, J. L. (2022) · Addiction · doi:10.1111/add.15792 · Cited by 58 · see citing works

Association of Smoking With Postprocedural Complications Following Open and Endovascular Interventions for Intermittent Claudication

Reitz, K. M., Althouse, A. D., Meyer, J., Arya, S., Goodney, P. P., Shireman, P. K., Hall, D. E., & Tzeng, E. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.3979 · Cited by 56 · see citing works

Real-time video counselling for smoking cessation

Tzelepis, F., Paul, C. L., Williams, C. M., Gilligan, C., Regan, T. W., Daly, J., Hodder, R. K., Byrnes, E., Byaruhanga, J., McFadyen, T., et al. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012659.pub2 · Cited by 50 · see citing works

Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta‐analysis of randomized controlled trials

Thomas, K. H., Dalili, M. N., López-López, J. A., Keeney, E., Phillippo, D., Munafo, M. R., Stevenson, M., Caldwell, D. M., & Welton, N. J. (2021) · Addiction · doi:10.1111/add.15675 · Cited by 48 · see citing works

Smoking Cessation and Benefits to Cardiovascular Health: A Review of Literature

Okorare, O., Evbayekha, E. O., Adabale, O. K., Daniel, E., Ubokudum, D., Olusiji, S., & Antia, A. U. (2023) · Cureus · doi:10.7759/cureus.35966 · Cited by 49 · see citing works

Interventions to increase adherence to medications for tobacco dependence

Hollands, G. J., Naughton, F., Farley, A., Lindson, N., & Aveyard, P. N. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009164.pub3 · Cited by 49 · see citing works

Lifestyle management to prevent atherosclerotic cardiovascular disease: evidence and challenges

Trier, T. J. V., Mohammadnia, N., Snaterse, M., Peters, R. J. G., Jorstad, H. T., & Bax, W. A. (2021) · Netherlands Heart Journal · doi:10.1007/s12471-021-01642-y · Cited by 52 · see citing works

Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV

Ashare, R. L., Thompson, M., Serrano, K., Leone, F. T., Metzger, D. S., Frank, I., Gross, R., Hole, A. V., Mounzer, K., Collman, R. G., et al. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.03.011 · Cited by 47 · see citing works

New steps for treating alcohol use disorder

Campbell, E. J., Lawrence, A. J., & Perry, C. J. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4887-7 · Cited by 47 · see citing works

An Online Weight Loss Intervention for People With Obesity and Poorly Controlled Asthma

Johnson, O., Gerald, L. B., Harvey, J. R., Roy, G., Hazucha, H., Large, C., Burke, A. E., McCormack, M. C., Wise, R. A., Holbrook, J. T., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.02.040 · Cited by 46 · see citing works

Tobacco Addiction

Selby, P. L., & Zawertailo, L. A. (2022) · New England Journal of Medicine · doi:10.1056/nejmcp2032393 · Cited by 47 · see citing works

The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?

Pomrenze, M. B., Fetterly, T. L., Winder, D. G., & Messing, R. O. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13507 · Cited by 45 · see citing works

Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial

Pastorino, U., Ladisa, V., Trussardo, S., Sabia, F., Rolli, L., Valsecchi, C., Ledda, R. E., Milanese, G., Suatoni, P., Boeri, M., et al. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.07.007 · Cited by 45 · see citing works

Smoking cessation strategies for patients with asthma: improving patient outcomes

Perret, J., Boneveski, B., McDonald, C., & Abramson, M. (2016) · Journal of Asthma and Allergy · doi:10.2147/jaa.s85615 · Cited by 44 · see citing works

E‐cigarette use in England 2014–17 as a function of socio‐economic profile

Kock, L. S., Shahab, L., West, R., & Brown, J. (2018) · Addiction · doi:10.1111/add.14446 · Cited by 43 · see citing works

Designer receptor technology for the treatment of epilepsy

Lieb, A., Weston, M., & Kullmann, D. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.059 · Cited by 44 · see citing works

Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation

Clark, A., Tate, B., Urban, B., Schroeder, R., Gennuso, S. A., Ahmadzadeh, S., McGregor, D., Girma, B., Shekoohi, S., & Kaye, A. D. (2023) · Health Psychology Research · doi:10.52965/001c.81043 · Cited by 42 · see citing works

Cytisine for smoking cessation: A systematic review and meta-analysis

Ofori, S., Lu, C., Olasupo, O. O., Dennis, B. B., Fairbairn, N. S., Devereaux, P. J., & Mbuagbaw, L. C. E. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110936 · Cited by 42 · see citing works

Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital

Windle, S. B., Dehghani, P., Roy, N., Old, W. D., Grondin, F. R., Bata, I. R., Iskander, A., Lauzon, C., Srivastava, N. K., Clarke, A., et al. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.170377 · Cited by 42 · see citing works

Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Dogar, O. F., Keding, A., Gabe, R., Marshall, A., Huque, R., Barua, D., Fatima, R., Khan, A., Zahid, R., Mansoor, S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30312-0 · Cited by 42 · see citing works

A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence

Schnoll, R. A., Leone, F. T., Veluz‐Wilkins, A. K., Miele, A., Hole, A. V., Jao, N. C., Wileyto, E. P., Carroll, A. J., Kalhan, R., Patel, J. D., et al. (2019) · Psycho-Oncology · doi:10.1002/pon.4978 · Cited by 42 · see citing works

Acupuncture for smoking cessation: A systematic review and meta-analysis of 24 randomized controlled trials

Wang, J.-H., van Haselen, R. A., Wang, M., Yang, G., Zhang, Z., Friedrich, M., Wang, Y., Zhou, Y.-Q., Yin, M., Xiao, C.-Y., et al. (2019) · Tobacco Induced Diseases · doi:10.18332/tid/109195 · Cited by 41 · see citing works

Preventive care recommendations to promote health equity

Persaud, N., Sabir, A., Woods, H., Sayani, A., Agarwal, A., Chowdhury, M., de Leon-Demare, K., Ibezi, S., Jan, S. H., Katz, A., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230237 · Cited by 42 · see citing works

Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement

Kathuria, H., Detterbeck, F. C., Fathi, J. T., Fennig, K., Gould, M. K., Jolicoeur, D. G., Land, S. R., Massetti, G. M., Mazzone, P. J., Silvestri, G. A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201709-1858st · Cited by 39 · see citing works

Nicotine receptor partial agonists for smoking cessation (Review)

Cahill, K., Lf, S., & Lancaster, T. (2007) · Cited by 205 · see citing works

Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation

Tutka, P. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.10.1473 · Cited by 32 · see citing works

Role of nicotine receptor partial agonists in tobacco cessation

Murthy, P., Maity, N., & Chand, P. (2014) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.124709 · Cited by 7 · see citing works

Varenicline: An α4β2 Nicotinic Acetylcholine Receptor Partial Agonist as an Aid to Smoking Cessation

George, T. P. (2006) · CRC Press eBooks · doi:10.1201/9781420005431-23 · Cited by 1 · see citing works

Partial Nicotinic Acetylcholine (α4β2) Agonists as Promising New Medications for Smoking Cessation

Singh, J., & Budhiraja, S. (2009) · TSpace (University of Toronto)